HomeNewsBusinessMarketsBet on these 5 picks from insurance and asset management sectors for 2021

Bet on these 5 picks from insurance and asset management sectors for 2021

We continue to believe that the AUM growth story remains intact with the benefit of MTM gains more than compensating for the stressed inflows.

January 02, 2021 / 15:10 IST
Story continues below Advertisement

The Life insurance sector witnessed a sharp downturn at the onset of the pandemic with a shift of preference towards liquidity and fear of income loss. Recovery in the economy and fear for the loss of life sentiment has given the much-needed push to Protection products. That apart, annuity and other guaranteed return products have been in flavour due to declining interest rate regime.

Premium growth in the protection segment got a fillip from the price hikes implemented by the companies. This also drove value of new business (VNB) margins for most companies given that protection and guaranteed return products have higher margins when compared with ULIPs and par products. ULIP has remained subdued for a while now, but we believe the same will start recovering with improved market sentiments (usually a lag of 6-8 months).

Story continues below Advertisement

HDFC Life Insurance has been the outperformer in the sector in FY21, nevertheless, SBI Life Insurance and ICICI Prudential Life Insurance can be seen catching up in terms of stock performance in the last one month. We believe ICICI Prudential Life Insurance and SBI Life Insurance offer a favorable risk-return ratio and accordingly remain our top picks for the sector.

The General Insurance Industry, too, witnessed the pain in the initial 2-3 months of the lockdown. However, Q3 CY20 saw a sharp recovery in the GDPI mainly led by a price hike in the Fire segment and a rush in demand for Health products. However, the demand was seen fizzling out during the festive seasons due to a shift towards consumption spends.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show